SCHEMBL30752579

SCHEMBL30752579

Cc1nc(Cl)nc2c(F)c(Br)c(C(F)(F)F)cc12

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 1/20 0.30
▸ ENPP3 O14638 1/20 0.30
▸ ENPP1 P22413 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24616033 0.85 ENPP3 (0.31) ENPP3ENPP1
SCHEMBL30752617 0.82 GABRP (0.34) —
SCHEMBL27426463 0.81 — —
SCHEMBL31355659 0.80 GAA (0.30) —
SCHEMBL30750845 0.79 ENPP3 (0.30) ENPP3ENPP1
SCHEMBL30752602 0.78 PDE2A (0.34) —
SCHEMBL24616403 0.75 AR (0.33) ARENPP3ENPP1
SCHEMBL31355670 0.74 TRPV1 (0.31) —
SCHEMBL30752636 0.73 SMN1; SMN2 (0.43) —
SCHEMBL30475027 0.73 NFKB1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565579-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF KRAS Theras, Inc. (US) 2025-06-11 — — EP disclosed
Send feedback